Abdominal (central) obesity is the accumulation of fat around the waist and the internal organs (visceral fat). It is more dangerous than "evenly distributed" obesity and is closely linked to insulin resistance and metabolic syndrome.
The key point: abdominal obesity is assessed by waist circumference independently of BMI — the waist can be large even at a normal weight.
Why it is more dangerous than subcutaneous fat
Visceral fat around the organs is metabolically active: it releases pro-inflammatory substances, aggravates insulin resistance and raises the risk of diabetes and heart disease. Subcutaneous fat on the hips is, in that sense, less harmful.
How to measure it
The simplest way is waist circumference with a tape measure (per the WHO protocol). In addition, the waist-to-hip ratio (WHR) and the waist-to-height ratio are used — they reflect fat distribution more accurately than BMI.
Reference ranges
Waist circumference (IDF thresholds for Europeans):
| Men — increased risk | ≥ 94 cm |
| Women — increased risk | ≥ 80 cm |
| High risk (AHA/NHLBI) | men ≥ 102 cm · women ≥ 88 cm |
Calculate using this marker
Calculators where Abdominal obesity is used directly:
Frequently asked questions
What waist circumference is considered normal?
Roughly below 94 cm in men and below 80 cm in women (European IDF thresholds). Higher values indicate abdominal obesity and increased cardiometabolic risk even at a normal BMI.
Can you target visceral fat specifically?
You cannot "burn" belly fat locally, but visceral fat is the first to go with overall weight loss: a calorie deficit, regular activity and cutting fast carbohydrates noticeably shrink the waist.
Related terms
Sources
- Alberti KGMM et al. IDF consensus worldwide definition of the metabolic syndrome. Diabet Med, 2006
- Alberti KGMM et al. Harmonizing the Metabolic Syndrome. Circulation, 2009
- WHO — Waist Circumference and Waist–Hip Ratio (report)